Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serum-derived exosomal PD-L1 expression to predict anti-PD-1 response and in patients with non-small cell lung cancer
Yoshihisa Shimada, Jun Matsubayashi, Yujin Kudo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer
Yu Jin Lee, Kyeong Jin Shin, Young Chan Chae
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 4, pp. 877-889
Open Access | Times Cited: 76
Extracellular vesicles and particles impact the systemic landscape of cancer
Serena Lucotti, Candia M. Kenific, Haiying Zhang, et al.
The EMBO Journal (2022) Vol. 41, Iss. 18
Open Access | Times Cited: 75
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy
Reza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 74
The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells
Reza Hajihosseini, Leila Asef‐Kabiri, Hassan Yousefi, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 80
Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment
Ming-Tsung Hsu, Yu-Ke Wang, Yufeng Jane Tseng
Cancers (2022) Vol. 14, Iss. 3, pp. 732-732
Open Access | Times Cited: 64
HRS phosphorylation drives immunosuppressive exosome secretion and restricts CD8+ T-cell infiltration into tumors
Lei Guan, Bin Wu, Ting Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 53
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
Kabsoo Shin, Joori Kim, Se Jun Park, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Tumor-derived nanoseeds condition the soil for metastatic organotropism
Mengying Hu, Candia M. Kenific, Nancy Boudreau, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 70-82
Closed Access | Times Cited: 22
Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
Yo-Ting Tsai, Jeffrey Schlom, Renee N. Donahue
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 13
Blood protein biomarkers in lung cancer
Hong Huang, Yongfeng Yang, Yihan Zhu, et al.
Cancer Letters (2022) Vol. 551, pp. 215886-215886
Closed Access | Times Cited: 30
Forging New Therapeutic Targets: Efforts of Tumor Derived Exosomes to Prepare the Pre-Metastatic Niche for Cancer Cell Dissemination and Dormancy
Ranvir Bhatia, Joanna Chang, Jessian L. Munoz, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1614-1614
Open Access | Times Cited: 20
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
Naushad Ahmad Khan, Mohammad Asim, Kabir H. Biswas, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 19
Soluble biomarkers to predict clinical outcomes in non-small cell lung cancer treated by immune checkpoints inhibitors
Julien Ancel, Valérian Dormoy, Béatrice Nawrocki‐Raby, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises
Sara Bandini, Paola Ulivi, Tania Rossi
Cells (2024) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 7
Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21
Haojie Wang, Yijun Qi, Zijun Lan, et al.
Gene Therapy (2022) Vol. 30, Iss. 1-2, pp. 88-100
Closed Access | Times Cited: 23
Homogeneous, Simple, and Direct Analysis of Exosomal PD-L1 via Aptamer-Bivalent-Cholesterol-Anchor Assembly of DNAzyme (ABCzyme) for Tumor Immunotherapy
Jie Hao, Junyi Wang, Yan Dong, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 17, pp. 6854-6862
Closed Access | Times Cited: 15
Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
Kah Yee Goh, Terence You De Cheng, Su Chin Tham, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 508-508
Open Access | Times Cited: 14
Trx0237 Induces Apoptosis and Enhances Anti-Pd-1 Immunotherapeutic Efficacy in Anaplastic Thyroid Cancer
Qingyang Ning, Jiaye Liu, Xixi Zhu, et al.
(2025)
Closed Access
Exosomal PD-L1 and lactate versus tissue PD-L1 as biomarkers for clinical outcomes of PD-1 Blockade plus chemotherapy in metastatic esophagogastric signet ring cell carcinoma
Yuanyuan Tian, Weisong Shi, Jing Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Functional tumor-derived exosomes in NSCLC progression and clinical implications
Yuxin Gao, Jun Xie, Zhenya Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
TRx0237 induces apoptosis and enhances anti-PD-1 immunotherapeutic efficacy in anaplastic thyroid Cancer
Qingyang Ning, Jiaye Liu, Shijing Liu, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114610-114610
Closed Access
Fascaplysin Induces Apoptosis and Ferroptosis, and Enhances Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer (NSCLC) by Promoting PD-L1 Expression
Lianxiang Luo, Guangxiang Xu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13774-13774
Open Access | Times Cited: 20
The role of extracellular vesicle immune checkpoints in cancer
Weiming Zhang, Mingrong Ou, Ping Yang, et al.
Clinical & Experimental Immunology (2024) Vol. 216, Iss. 3, pp. 230-239
Open Access | Times Cited: 4
Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer
Jie Yao, Xuwen Lin, Xin Zhang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Clinical Impact of Exosome Chemistry in Cancer
Shrishti Madhan, Rajib Dhar, Arikketh Devi
ACS Applied Bio Materials (2025)
Closed Access
Page 1 - Next Page

Scroll to top